A meeting on the current recommendations for the treatment of atherogenic dyslipidemia, organized by the Clinic of Endocrinology, Military Medical Academy was held at the Military Medical Academy.

MMA’s Deputy Head Col. Prof. Dr. Dragan Dincic and Head of Clinic of Endocrinology Col. Prof. Dr. Zoran Hajdukovic spoke about hyperlipidemia and its treatment especially in patients with a high risk factor for the occurrence of cardiovascular disease. From cardiological and endocrinological point of view, and in accordance with the latest international recommendations, lectures encompassed the lipoprotein disorders as important factors of cardiovascular disease.

In addition to the current knowledge about dyslipidemia, the NON-HDL cholesterol as an important factor in the group of more than 200 risk factors for ischemic heart disease was highlighted. Attendees had the opportunity to hear the details of the metabolic process and the specifics of the treatment, but also about the target values of lipid disorders in the prevention of cardiovascular diseases, the use of the newer generation of medications and results of clinical studies. As noted, the reduction of risk factors for the disease can often bring greater benefit than treatment process itself, and this is particularly important in the case of coronary heart disease - a leading cause of death of a modern man.